Paolo Pucci
Direktor/Vorstandsmitglied bei WEST PHARMACEUTICAL SERVICES, INC.
Vermögen: 4 Mio $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Philip Astley-Sparke | M | 51 | 9 Jahre | |
| Bill Lundberg | M | 60 | 5 Jahre | |
| Robert Coffin | M | 58 | 9 Jahre | |
| Peter Silverman | M | 46 | 7 Jahre | |
| Kapil Dhingra | M | 64 | 12 Jahre | |
| Sushil Patel | M | 52 | 3 Jahre | |
| Bernard Birkett | M | 55 | 6 Jahre | |
| Eric Green | M | 55 | 9 Jahre | |
| Gregory Perry | M | 63 | 8 Jahre | |
| Anand Mehra | M | 48 | 9 Jahre | |
| Sushant Kumar | M | - |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
| Mark Iwicki | M | 57 | 9 Jahre | |
| Dieter Weinand | M | 63 | 6 Jahre | |
| Molly Joseph | F | 50 | 3 Jahre | |
| Douglas Michels | M | 66 | 13 Jahre | |
| Silji Abraham | M | 52 | 6 Jahre | |
| Christy Oliger | F | 54 | 3 Jahre | |
| Kimberly MacKay | F | 58 | 4 Jahre | |
| Victor Sandor | M | 57 | 5 Jahre | |
| Len Kanavy | M | 62 | 6 Jahre | |
| Andrew Schwendenman | M | 47 | 4 Jahre | |
| Cindy Reiss-Clark | F | 50 | - | |
| Andrew Muratore | M | - | 3 Jahre | |
| Deborah Baron | F | 55 | 3 Jahre | |
| Deborah Keller | F | 61 | 7 Jahre | |
| Veleka Peeples-Dyer | F | 52 | 1 Jahre | |
| Robert Glassman | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 3 Jahre |
| Stephen Lockhart | M | 65 | 2 Jahre | |
| William Feehery | M | 54 | 12 Jahre | |
| Robert Friel | M | 68 | 4 Jahre | |
| Thomas Hofmann | M | 72 | 17 Jahre | |
| Joseph Slattery | M | 59 | 7 Jahre | |
| Mark Buthman | M | 63 | 13 Jahre | |
| Myla Lai-Goldman | M | 66 | 10 Jahre | |
| David Epstein | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 Jahre |
| Hyam Levitsky | M | 66 | 6 Jahre | |
| Peter Molloy | M | 52 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
| Sherri L. Spear | F | - | - | |
| Cecilia Anna Wilhelmina Geuijen | M | 56 | 3 Jahre | |
| Donald A. McMillan | M | 65 | 27 Jahre | |
| Christopher Sarchi | M | 55 | 1 Jahre | |
| Konstantinos Xynos | M | 57 | 2 Jahre | |
| Michele Polinsky | M | - | - | |
| Chris Ryan | M | - | - | |
| Ernesto Wasserman | M | - | 8 Jahre | |
| Ashley Pereira | M | - | 3 Jahre | |
| Shannon Campbell | F | 58 | 2 Jahre | |
| Alexander Berthold Hendrik Bakker | M | 57 | 14 Jahre | |
| Kathleen Farren | F | - | - | |
| C. Nicholson | M | 68 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 Jahre |
| Emily Hill | F | 44 | 1 Jahre | |
| Andrew Joe | M | 58 | 4 Jahre | |
| Harry Shuman | M | - | - | |
| John de Kruif | M | 60 | 17 Jahre | |
| Liu Hui | M | 51 | 9 Jahre | |
| Quintin Lai | M | 57 | 8 Jahre | |
| Jason Haddock | M | 54 | - | |
| Annette Favorite | F | 59 | 9 Jahre | |
| Paul Achleitner | M | 67 | 22 Jahre | |
| Mark S. Cohen | M | 56 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Andrew Ashe | M | 57 | 13 Jahre | |
| George Migausky | M | 69 | 8 Jahre | |
| Jean Franchi | F | 57 | 4 Jahre | |
| Gustav Christensen | M | 76 | 9 Jahre | |
| James Parsons | M | 58 | 10 Jahre | |
| David J. McLachlan | M | 86 | 17 Jahre | |
| Patrick Zenner | M | 77 | 20 Jahre | |
| Jan Skvarka | M | 57 | 2 Jahre | |
| Robert A. Uger | M | 53 | 8 Jahre | |
| Ivana Magovcevic-Liebisch | M | 55 | 12 Jahre | |
| Robert L. Kirkman | M | 75 | 8 Jahre | |
| Henry E. Blair | M | 80 | 27 Jahre | |
| Jason Rhodes | M | 54 | 7 Jahre | |
| Paul Walker | M | 49 | 1 Jahre | |
| Bernd Metzner | M | 53 | 4 Jahre | |
| Thomas Lenox Kempner | M | 96 | 21 Jahre | |
| Johannes M. Dietsch | M | 62 | 16 Jahre | |
| Willy Beumann | M | 68 | - | |
| Klaus Sturany | M | 77 | - | |
| Penka Petrova | M | 56 | 8 Jahre | |
| Scott Myers | M | 57 | - | |
| Thomas Hoffmann | M | 53 | 5 Jahre | |
| Joseph Saluri | M | 57 | 7 Jahre | |
| Helmut Gunter Wilhelm Panke | M | 77 | - | |
| Paula Johnson | M | 64 | 16 Jahre | |
| Ronald Cohen | M | 68 | 5 Jahre | |
| James Fordyce | M | 81 | 21 Jahre | |
| Michael A. Anderson | M | 68 | 24 Jahre | |
| David Montecalvo | M | 58 | 6 Jahre | |
| Henry Lewis | M | 98 | 17 Jahre | |
| Susan B. Bayh | F | 64 | 9 Jahre | |
| John Weiland | M | 68 | 12 Jahre | |
| Tanya Lewis | F | 53 | 4 Jahre | |
| Marc Kozin | M | 62 | 4 Jahre | |
| Klaus-Christian Kleinfeld | M | 65 | 9 Jahre | |
| Mary Gray | M | 71 | 12 Jahre | |
| William Federici | M | 64 | 15 Jahre | |
| Chad Johnson | M | 45 | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 37 | 37,76% |
| Schweiz | 25 | 25,51% |
| Niederlande | 19 | 19,39% |
| Kanada | 9 | 9,18% |
| Deutschland | 8 | 8,16% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Paolo Pucci
- Persönliches Netzwerk
